Middle East Wound Gel Market Size, Share & Trends Analysis, By Product (Dressings, Gels), By Antimicrobial Properties (Silver, Non-silver), By Application, By Mode of Purchase, By Distribution Channel, By End Use, By Country, And Segment Forecasts, 2025 -
Description
Middle East Wound Gel Market Summary
The Middle East wound gel market size was estimated at USD 137.38 million in 2024 and is projected to reach USD 206.81 million by 2033, growing at a CAGR of 4.67% from 2025 to 2033. The increasing number of surgical procedures is a key driver for the growth of the wound gel market in the Middle East.
Post-operative wounds require effective management to reduce infection risks and enhance healing. Advanced wound care products like wound gels are gaining preference in the region due to their ability to maintain a moist healing environment, promote autolytic debridement, and support faster tissue regeneration, making them essential in post-surgical wound care. The growing aging population in the Middle East is a significant driver of growing demand for the wound gel industry. As the region experiences a rise in age-related diseases such as cardiovascular issues, cancer, diabetes, neurological disorders, and musculoskeletal conditions, the need for surgical interventions increases accordingly.
For instance, according to the study published by Frontiers in February 2025, over half (52%) of the participants had two or more chronic diseases, with hypercholesterolemia, hypertension, and type 2 diabetes being the most common in Saudi Arabia. Wound gels support effective wound management and healing in chronic disease treatments and associated procedures. The growing prevalence of chronic illnesses among older adults drives the adoption of advanced surgical technologies and wound gel products, to improve treatment outcomes and enhance patient recovery in the Middle East.
In addition, the increasing prevalence of diabetes and related complications is anticipated to propel the demand for wound gel products across the Middle East. With a growing number of diabetic patients in the region, there is a higher incidence of chronic wounds such as diabetic foot ulcers and pressure sores, which require advanced wound gel solutions. Wound gels, known for maintaining a moist healing environment and preventing infections, are becoming essential in managing these difficult-to-heal wounds. This rising burden of diabetes and its complications significantly boosts the demand for effective wound gel products across the Middle East. According to the data provided by the International Diabetes Federation (IDF), the prevalence of diabetes is increasing in the Middle East, with countries such as Qatar, Saudi Arabia, and the UAE showing notably high rates among their adult populations. This rising prevalence highlights the growing need for effective diabetes management and related healthcare products, including advanced wound gel solutions, to address complications like diabetic foot ulcers.
Middle East Wound Gel Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East wound gel market report based on type, product, antimicrobial properties, application, mode of purchase, distribution channel, end use, and country:
The Middle East wound gel market size was estimated at USD 137.38 million in 2024 and is projected to reach USD 206.81 million by 2033, growing at a CAGR of 4.67% from 2025 to 2033. The increasing number of surgical procedures is a key driver for the growth of the wound gel market in the Middle East.
Post-operative wounds require effective management to reduce infection risks and enhance healing. Advanced wound care products like wound gels are gaining preference in the region due to their ability to maintain a moist healing environment, promote autolytic debridement, and support faster tissue regeneration, making them essential in post-surgical wound care. The growing aging population in the Middle East is a significant driver of growing demand for the wound gel industry. As the region experiences a rise in age-related diseases such as cardiovascular issues, cancer, diabetes, neurological disorders, and musculoskeletal conditions, the need for surgical interventions increases accordingly.
For instance, according to the study published by Frontiers in February 2025, over half (52%) of the participants had two or more chronic diseases, with hypercholesterolemia, hypertension, and type 2 diabetes being the most common in Saudi Arabia. Wound gels support effective wound management and healing in chronic disease treatments and associated procedures. The growing prevalence of chronic illnesses among older adults drives the adoption of advanced surgical technologies and wound gel products, to improve treatment outcomes and enhance patient recovery in the Middle East.
In addition, the increasing prevalence of diabetes and related complications is anticipated to propel the demand for wound gel products across the Middle East. With a growing number of diabetic patients in the region, there is a higher incidence of chronic wounds such as diabetic foot ulcers and pressure sores, which require advanced wound gel solutions. Wound gels, known for maintaining a moist healing environment and preventing infections, are becoming essential in managing these difficult-to-heal wounds. This rising burden of diabetes and its complications significantly boosts the demand for effective wound gel products across the Middle East. According to the data provided by the International Diabetes Federation (IDF), the prevalence of diabetes is increasing in the Middle East, with countries such as Qatar, Saudi Arabia, and the UAE showing notably high rates among their adult populations. This rising prevalence highlights the growing need for effective diabetes management and related healthcare products, including advanced wound gel solutions, to address complications like diabetic foot ulcers.
Middle East Wound Gel Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East wound gel market report based on type, product, antimicrobial properties, application, mode of purchase, distribution channel, end use, and country:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Dressings
- Hydrogel dressing
- Gelling fiber dressings
- Others
- Gels
- Antimicrobial Properties Outlook (Revenue, USD Million, 2021 - 2033)
- Silver (Ag+)
- Non-silver
- Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
- Prescription
- Non-Prescription
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Offline
- Online
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Chronic Wounds
- Diabetic Foot Ulcers (DFUs)
- Pressure Ulcers
- Stage 1
- Stage 2
- Stage 3
- Stage 4
- Leg Ulcers
- Acute Wounds
- Surgical Incisions
- Burns
- 1st Degree
- 2nd Degree
- 3rd Degree
- Lacerations, Abrasions
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
- Homecare Settings
- Long-Term Care Facilities
- Others
- Country Outlook (Revenue, USD Million, 2021 - 2033)
- Saudi Arabia
- UAE
- Kuwait
- Qatar
- Oman
Table of Contents
110 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Antimicrobial Properties
- 1.1.3. Application
- 1.1.4. Mode of Purchase
- 1.1.5. Distribution Channel
- 1.1.6. End-use
- 1.1.7. Country scope
- 1.1.8. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Middle East Wound Gel Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing number of surgical procedures
- 3.2.1.2. Aging population and rising diabetes cases
- 3.2.1.3. Introduction of innovative and advanced wound gel Market restraint analysis
- 3.2.1.4. Lack of Awareness and Educational Gaps
- 3.2.2. Market opportunity analysis
- 3.2.2.1. Rising Cases of Diabetic Ulcers, Pressure Ulcers, and Burns
- 3.2.2.2. Growing number of clinical trials
- 3.2.2.3. Expanding Healthcare Infrastructure and Government Support
- 3.2.3. Market challenge analysis
- 3.2.3.1. Regulatory Hurdles
- 3.3. Middle East Wound Gel Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- Chapter 4. Middle East Wound Gel Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Middle East Wound Gel Market Product Movement Analysis
- 4.3. Middle East Wound Gel Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. Dressings
- 4.4.1. Dressings market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.4.1.1. Hydrogel dressings
- 4.4.1.1.1. Hydrogel dressings market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.4.1.2. Gelling fiber dressings
- 4.4.1.2.1. Gelling fiber dressings market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.4.1.3. Others
- 4.4.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.5. Gels
- 4.5.1. Gels market estimates and forecasts for 2021 to 2033 (USD Million)
- Chapter 5. Middle East Wound Gel Antimicrobial Properties: Product Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Middle East Wound Gel Market Product Movement Analysis
- 5.3. Middle East Wound Gel Market Size & Trend Analysis, by Antimicrobial Properties, 2021 to 2033 (USD Million)
- 5.4. Silver
- 5.4.1. Silvers market estimates and forecasts for 2021 to 2033 (USD Million)
- 5.5. Non-silver
- 5.5.1. Non silver market estimates and forecasts for 2021 to 2033 (USD Million)
- Chapter 6. Wound Gel Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Middle East Wound Gel Market Application Movement Analysis
- 6.3. Middle East Wound Gel Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 6.4. Chronic Wounds
- 6.4.1. Chronic wounds market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.4.1.1. Diabetic foot ulcers
- 6.4.1.1.1. Diabetic foot ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.4.1.2. Pressure ulcers
- 6.4.1.2.1. Pressure ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.4.1.2.1.1. Stage 1
- 6.4.1.2.1.1.1. Stage 1 market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.4.1.2.1.2. Stage 2
- 6.4.1.2.1.2.1. Stage 2 market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.4.1.2.1.3. Stage 3
- 6.4.1.2.1.3.1. Stage 3 market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.4.1.2.1.4. Stage 4
- 6.4.1.2.1.4.1. Stage 4 market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.4.1.3. Leg ulcers
- 6.4.1.3.1. Leg ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.5. Acute Wounds
- 6.5.1. Acute wounds market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.5.1.1. Surgical incisions
- 6.5.1.1.1. Surgical incisions market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.5.1.2. Burns
- 6.5.1.2.1. Burns market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.5.1.2.1.1. 1st degree burns
- 6.5.1.2.1.1.1. 1st degree burns market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.5.1.2.1.2. 2nd degree burns
- 6.5.1.2.1.2.1. 2nd degree burns market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.5.1.2.1.3. 3rd degree burns
- 6.5.1.2.1.3.1. degree burns market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.5.1.3. Lacerations & abrasions
- 6.5.1.3.1. Lacerations & abrasions market estimates and forecasts for 2021 to 2033 (USD Million)
- Chapter 7. Middle East Wound Gel Market: Mode of Purchase Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Middle East Wound Gel Market Mode of Purchase Movement Analysis
- 7.3. Middle East Wound Gel Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
- 7.4. Prescription
- 7.4.1. Prescription market estimates and forecasts for 2021 to 2033 (USD Million)
- 7.5. Non-Prescription
- 7.5.1. Non-Prescription market estimates and forecasts for 2021 to 2033 (USD Million)
- Chapter 8. Middle East Wound Gel Devices: Distribution Channel Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Middle East Wound Gel Market Distribution Channel Movement Analysis
- 8.3. Middle East Wound Gel Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
- 8.4. Offline
- 8.4.1. Offline market estimates and forecasts for 2021 to 2033 (USD Million)
- 8.5. Online
- 8.5.1. Online market estimates and forecasts for 2021 to 2033 (USD Million)
- Chapter 9. Wound Gel Devices: End Use Estimates & Trend Analysis
- 9.1. Segment Dashboard
- 9.2. Middle East Wound Gel Market End Use Movement Analysis
- 9.3. Middle East Wound Gel Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 9.4. Hospitals
- 9.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
- 9.5. Specialty Clinics
- 9.5.1. Specialty clinics market estimates and forecasts for 2021 to 2033 (USD Million)
- 9.6. Ambulatory Surgery Centers
- 9.6.1. Ambulatory surgery centers market estimates and forecasts for 2021 to 2033 (USD Million)
- 9.7. Homecare Settings
- 9.7.1. Homecare settings market estimates and forecasts for 2021 to 2033 (USD Million)
- 9.8. Long-Term Care Facilities
- 9.8.1. Long-term care facilities market estimates and forecasts for 2021 to 2033 (USD Million)
- 9.9. Others
- 9.9.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
- Chapter 10. Middle East Wound Gel Market: Country Estimates & Trend Analysis
- 10.1. Regional Dashboard
- 10.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 10.3. Middle East
- 10.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
- 10.3.2. UAE
- 10.3.2.1. Key country dynamics
- 10.3.2.2. Competitive scenario
- 10.3.2.3. Regulatory framework
- 10.3.2.4. Reimbursement scenario
- 10.3.2.5. UAE market estimates and forecasts, 2021 - 2033
- 10.3.3. Saudi Arabia
- 10.3.3.1. Key country dynamics
- 10.3.3.2. Competitive scenario
- 10.3.3.3. Regulatory framework
- 10.3.3.4. Reimbursement scenario
- 10.3.3.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
- 10.3.4. Kuwait
- 10.3.4.1. Key country dynamics
- 10.3.4.2. Competitive scenario
- 10.3.4.3. Regulatory framework
- 10.3.4.4. Reimbursement scenario
- 10.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
- 10.3.5. Oman
- 10.3.5.1. Key country dynamics
- 10.3.5.2. Competitive scenario
- 10.3.5.3. Regulatory framework
- 10.3.5.4. Reimbursement scenario
- 10.3.5.5. Oman market estimates and forecasts, 2021 - 2033
- 10.3.6. Qatar
- 10.3.6.1. Key country dynamics
- 10.3.6.2. Competitive scenario
- 10.3.6.3. Regulatory framework
- 10.3.6.4. Reimbursement scenario
- 10.3.6.5. Qatar market estimates and forecasts, 2021 - 2033
- Chapter 11. Competitive Landscape
- 11.1. Recent Developments & Impact Analysis, By Key Market Participants
- 11.2. Company/Competition Categorization
- 11.2.1. Innovators
- 11.3. Vendor Landscape
- 11.3.1. List of key distributors and channel partners
- 11.3.2. Key customers
- 11.3.3. Key company market share analysis, 2024
- 11.3.4. Solventum
- 11.3.4.1. Company overview
- 11.3.4.2. Financial performance
- 11.3.4.3. Product benchmarking
- 11.3.4.4. Strategic initiatives
- 11.3.5. Molnlycke AB
- 11.3.5.1. Company overview
- 11.3.5.2. Financial performance
- 11.3.5.3. Product benchmarking
- 11.3.5.4. Strategic initiatives
- 11.3.6. Medline Industries, LP.
- 11.3.6.1. Company overview
- 11.3.6.2. Financial performance
- 11.3.6.3. Product benchmarking
- 11.3.6.4. Strategic initiatives
- 11.3.7. Coloplast Ltd
- 11.3.7.1. Company overview
- 11.3.7.2. Financial performance
- 11.3.7.3. Product benchmarking
- 11.3.7.4. Strategic initiatives
- 11.3.8. Convatec Inc.
- 11.3.8.1. Company overview
- 11.3.8.2. Financial performance
- 11.3.8.3. Product benchmarking
- 11.3.8.4. Strategic initiatives
- 11.4. Heat Map Analysis/ Company Market Position Analysis
- 11.5. Estimated Company Market Share Analysis, 2024
- 11.6. List of Other Key Market Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


